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Abstract 
Atherosclerotic diseases are mainly caused by coronary and peripheral blood vessel disorders. 
Endothelial dysfunction represents an early phase in these diseases, when patients are generally 
asymptomatic.  
We developed a technique, based on near infrared spectroscopy (NIRS), for measurement of 
arterial blood flow variations in limbs during reactive hyperemia. The technique allows the study 
of the level of vascular impairment and probably quantifying the level of endothelial dysfunction 
at peripheral arteries.  
The experiment was performed on two cohorts of 13 and 15 patients and was compared to strain 
gauge plethysmography (SGP) which is considered as gold standard.  
Afterward, we characterized endothelial reaction during reactive hyperemia through blood flow 
variations by modeling the hyperemic curve. Preliminary studies have shown that the hyperemic 
response generally adopts a bimodal form. The first peak was attributed to myogenic reaction 
that is endothelial independent and the second one to local endothelial cells reaction. The 
quantification of the two hyperemic response components makes it possible to calculate an index 
of ‘health’ for local endothelial cells, named ηfactor.  
The results showed a strong correlation (r = 0.91) of blood flow measurements between the 
developed method and the gold standard.  We concluded that NIRS is a precise technique for 
non-invasive measurement of blood flow. Moreover, we found a high repeatability (ICC = 
0.9313) of the ηfactor in repeated measurements indicating its robustness. Nonetheless, more 
studies are required to validate the diagnosis value of the defined factor.  
 
Key words: reactive hyperemia, myogenic response, endothelial dependent vasodilatation, nitric 
oxide, atherosclerosis, near infrared spectroscopy (NIRS) 
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Résumé 
L’atteinte de la fonction endothéliale représente une phase précoce de l’athérosclérose, un stade 
où les patients sont généralement asymptomatiques. Il existe donc un intérêt certain à détecter la 
dysfonction endothéliale. 
Nous avons développé une technique de mesure des variations de flot artériel au niveau des 
membres supérieurs, basée sur la spectroscopie proche infrarouge (NIRS). Cette approche 
permettrait d’étudier le niveau d’atteinte vasculaire et probablement de quantifier le degré de 
dysfonction endothéliale périphérique lors d’une hyperémie réactive.  
L'expérience a été exécutée sur deux cohortes de 13 et de 15 patients et a été comparée à la 
pléthysmographie par jauge de contrainte (SGP) qui est considérée comme une méthode de 
référence. 
Par la suite, nous avons caractérisé la réponse endothéliale par modélisation de la courbe 
hyperémique du flot artériel. Des études préliminaires avaient démontré que la réponse 
hyperémique adoptait majoritairement une forme bi-modale. Nous avons tenté de séparer  les 
composantes endothéliales-dépendantes et endothéliales-indépendantes de l’hyperémie. La 
quantification des deux composantes de la réaction hyperémique permet de calculer un indice de 
la ‘santé’ du système endothélial local. Cet indice est nommé le ηfactor. 
Les résultats montrent une forte corrélation des mesures de flots entre la technique développée et 
la méthode de référence (r=0.91).  Nous avons conclu que NIRS est une approche précise pour la 
mesure non-invasive du flot artériel. Nous avons obtenu une bonne répétabilité (ICC = 0.9313) 
pour le ηfactor indiquant sa robustesse. Cependant des études supplémentaires sont nécessaires 
pour valider la valeur de diagnostic du facteur défini. 
 
Mots clés: hyperémie réactive, réponse myogénique, oxyde nitrique, athérosclérose, 
spectroscopie proche infrarouge 
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Chapter 1: Introduction 
Atherosclerotic diseases are one of the major causes of death and morbidity. Common conditions 
such as hypercholesterolemia, hypertension, diabetes, and smoking are associated with 
endothelial dysfunction. These conditions prompt atherosclerosis, indicating the fact that 
endothelial dysfunction is a premature stage in atherosclerotic diseases, where patients are 
generally asymptomatic [1]. 
Endothelium plays a critical role in modulation of the tone of the underlying vascular smooth 
muscle cells through release of a variety of autocrine and paracrine substances [2]. Importantly, a 
healthy endothelium inhibits platelet and leukocyte adhesion to the vascular surface, thereby 
limiting thrombosis.  
Nitric oxide (NO) appears to be a particularly important relaxing factor produced by endothelial 
cells. NO inhibits adhesion and aggregation, maintaining the balance of prothrombotic activity 
[3, 4].  In patients with coronary diseases, platelet derived NO production is remarkably reduced. 
This condition is considered as an independent predictor of acute coronary events [5].  
Endothelial function has been assessed largely in terms of endothelial dependent vasodilatation, 
based on the results showing that this response is impaired in patients with atherosclerosis risk 
factors.  This condition can be assessed in catheterization laboratory by coronary intra-arterial 
infusion of NO agonists, such as acetylcholine (ACh) [6]. Particularly, stimuli that increase 
production of endothelium-derived NO are used in evaluation of endothelial dependent 
vasodilatation in humans. Such stimuli include increased shear stress from increased blood flow 
and infusion of NO agonists such as acetylcholine, bradykinin, or a neuropeptide known as 
substance P. Several studies have been developed to assess endothelial function non-invasively 
in peripheral arteries. It has been established that endothelial function in coronary artery is 
strongly related to that in a peripheral conduit vessel [7]. 
Strain gauge plethysmography (SGP) is the gold standard method for non-invasive assessment of 
endothelial function by intra-arterial infusion of ACh [8]. However arterial catheterization for 
ACh injection is needed in this method. Reactive hyperemia (RH) is a less invasive method to 
stimulate endothelial cells activation. The technique is based on creation of an acute increase in 
the limb blood flow through a temporary ischemic condition. The transition state at the release of 
ischemia induces remarkable amount of shear stress on vascular endothelium that stimulates 
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release of NO from endothelial cells [9-11]. We used a near infrared spectroscopy (NIRS) device 
to monitor tissue oxygenation state during reactive hyperemia. The device provides different 
parameters such as total hemoglobin variations at relatively high sampling rate (6 Hz). We were 
interested in the relation between oxygenation state and arterial inflow. We assumed that 
variations in total hemoglobin in terms of time correlate with total blood volume changes.   
It was to our interest to evaluate the endothelial function and particularly the NO dependent 
vasodilatation by monitoring the peripheral arterial flow variations during the reactive 
hyperemia. Endothelial function assessment results in identification of a group of patients who 
are relatively at higher risks for cardiovascular events but yet not qualified for medical therapy 
according to current medical guidelines. This group of patients would benefit from a more 
aggressive medical or lifestyle treatment.  
The purpose of this study is: 
1) Evaluate the ability of the NIRS device to measure forearm blood flow during reactive 
hyperemia by comparing to SGP; 
2) Characterize the function of blood flow variations measured by NIRS plethysmography 
(NIRSP), during reactive hyperemia. 
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Chapter 2: Literature review 
Heart and blood vessels form the cardiovascular system. Blood vessels play an important role in 
initialization and development of atherosclerotic vascular diseases. They consist of three 
different layers through which vascular tone is controlled. Each layer contributes to vascular tone 
through different mechanisms. Endothelium, which is the inner most layer of blood vessels, has a 
significant contribution to this regulation.   
This chapter presents a brief introduction on different mechanisms of vascular tone regulation 
along with their effect on blood flow variation. Afterwards, non-invasive methods of blood flow 
measurement are presented.     
2.1 Blood vessel wall 
Blood vessels transport blood throughout the whole body. There are three general types of blood 
vessels: arteries, veins and capillaries. Arteries carry blood away from the heart while the veins 
carry it back to the heart. Arteries and veins are connected by capillaries, where the exchange of 
nutrients and chemical wastes is carried out.  
Except for capillaries, the two other types of blood vessels consist of three layers: intima, media 
and adventitia (Figure 2-1). 
The intima is a fine layer of endothelial cells in direct contact with circulating blood. Endothelial 
cells are oriented along the axis of the blood vessels and blood flow. This specific orientation 
streamlines the endothelial cells to decrease the resistance of the vessels to blood flow.  
The media includes smooth muscle cells and is composed of collagen and elastin. It contains 
terminal nerve endings in some parts, particularly in veins.  
The adventitia which is the outermost layer of blood vessels is a fiber elastic layer and it contains 
terminal nerve endings as well.  
Capillaries consist of a layer of endothelial cells surrounded by pericytes that control the vessel 
diameter. 
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Figure 2-1: Blood vessel wall components: intima, media and adventitia. 
 
2.1.1 Endothelium (intima) 
Endothelium is a fine layer of cells in direct contact with circulating blood. It has functional 
characteristics of an organ as it controls different functions: 
1) Blood pressure control (through vasoconstriction and vasodilatation), 
2) Blood fluidity, 
3) Angiogenesis, 
4) Synthesis and degradation of extra cellular matrix, 
5) Inflammation. 
The healthy endothelium mediates endothelial dependent vasodilatation along with suppression 
of thrombosis and vascular inflammation. Therefore, the healthy layer of endothelium is crucial 
for normal operation of vessels. Endothelium is located strategically to serve as a sensory cell. 
They participate in vascular remodeling and activation of substances in response to different 
kinds of physical and chemical stimuli. The pathways mediating the response of endothelium to 
stimuli are complicated and yet to be fully understood.  
The endothelial surface is constantly exposed to two categories of stimuli: 
 
- Chemical substances such as neurotransmitters and inflammatory mediators; 
- Hemodynamic forces such as shear stress.   
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There are a variety of receptors on the surface of endothelial cells to detect physical and 
chemical stimuli (Figure 2-2). The detected signal is then relayed within the cells and to adjacent 
cells. In response, endothelial cells release activation substances that influence the cell growth 
and death, vasodilatation, vasoconstriction and extra cellular matrix composition. 
 
 
Figure 2-2: Vascular remodeling agents: signals, sensors and mediators [2]. 
 
Endothelial cells, as well as smooth muscle cells, are connected via gap junctions.                                           
 
Endothelial dependent vasodilatation  
As vasodilator substances, endothelium releases either relaxing factors, called endothelial 
dependent relaxing factors (EDRF), or hyperpolarizing factors, called endothelial dependent 
hyperpolarizing factors (EDHF). Both categories of substances lead to vasodilatation but through 
different pathways.  
Endothelial dependent vasodilatation is triggered by either chemical substances such as 
acetylcholine, or hemodynamic stimuli such as shear stress. The result is release of EDRF. Nitric 
oxide (NO) appears to be a particularly important relaxing factor produced by endothelial cells. 
It is a mediator of endothelium dependent vasodilatation as well as having anti-inflammatory and 
antithrombotic effect. NO is highly reactive with a half life in the order of a few seconds (2-5 s) 
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and it diffuses rapidly through cell membranes [3]. Therefore its chemical characteristics make it 
an excellent agent for short-term and localized responses. NO is synthesized from L-arginine (L-
Arg), an amino acid, and oxygen in the presence of enzyme NO synthase (NOS) [4]. 
Ohno et al. verified the signal transduction pathway of flow induced release of EDRF [12]. Shear 
stress or the agents with vasoactive properties interact with specific receptors that are located on 
endothelial cells surface. Consequently, intracellular calcium concentration in endothelial cell 
increases. Calcium activates NOS, an enzyme that is necessary for NO synthesis. NO reaches 
other endothelial and smooth muscle cells in the neighborhood. NO in smooth muscle cells 
stimulates another enzyme sGC (soluble guanylyl cyclase) that synthesizes cyclic guanosine 
monophosphate (cGMP). Cyclic GMP acts as a second messenger and it activates intracellular 
protein kinases that mediate smooth muscle cells relaxation and vasodilatation (Figure 2-3). 
However, the pathway by which protein kinases mediates smooth muscle relaxation remains to 
be fully understood.   
There are other endothelial dependent vasodilator agents other than NO, such as prostacyclin 
(PGI2) (Table 2-1).  
PGI2 is another relaxing and anti-thrombosis agent that is released from endothelial cells. 
Increased calcium activates NOS and phospholipase A2 (PLA2) as well. Activated PLA2 forms 
prostacyclin metabolism of arachidonic acid (AA) and cyclo oxygenase, (COX)-1.  
Mitchell et al. showed that prostacyclin and NO are coreleased from endothelial cells and they 
act in synergy to inhibit platelet activation and limiting thrombosis [4].   
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Figure 2-3: The pathway of endothelial derived relaxing factor release [12-14]. 
 
There is another relaxant pathway mediated by endothelial cells. EDHF, whose chemical 
composition is unknown, causes arterial vessels to dilate while NO and prostacyclin productions 
are inhibited. Potassium channels blocker stops the vasodilatory effect of EDHF, indicating their 
involvement in the mechanisms of EDHF-mediated vasodilatation. The contribution of EDHF 
mediated response seems to be greater in smaller vessels [13]. EDHF is known to be released by 
endothelial cells in response to shear stress but little is known about its mechanism. It seems that 
the presence of shear stress causes the increase of intracellular calcium concentration in 
endothelial cells which activates calcium dependent potassium (KCa) channels. Opening of the 
endothelial KCa channels causes potassium ions to be accumulated in the intracellular space 
between endothelial cells and smooth muscle cells. Increase in myo-endothelial potassium 
concentration induces hyperpolarization of vascular smooth muscle cells [13]. Table 2-1 
summarizes some of the known responses of endothelium to mechanical forces [15]. 
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Mechanical force effects Significance Response time 
Release of NO Vasodilatation secs 
Release of acetylcholine and 
substance P 
Neurotransmitter release secs 
Activation of adenylate 
cylase 
Vasodilatation mins 
Release of prostacyclin 
(PGI2) 
Vasodilatation and  
antithrombotic regulation 
< 2 min 
Release of EDHF Vasodilatation unknown 
 
Release of endothelin Vasoconstriction 2-4 h 
Angiotensin II Vasoconstriction unknown 
Decrease of intracellular pH Modulation of ionic 
balance 
> 3 h 
Cell alignment in direction 
of flow 
Minimizes drag on 
endothelial cells 
> 6h 
LDL metabolism stimulation Endothelial cholesterol 
balance 
24h 
Mechanical stiffness of cell 
surface 
Deformability decrease 24 h 
 
Table 2-1: Responses of endothelium to mechanical forces including shear stress and stretch [15]. 
    
Endothelium response to physical and chemical stimuli in subjects with and without 
atherosclerotic diseases has been studied by many researchers. Anderson et al. compared the 
endothelial dependent vasodilatation in brachial and coronary arteries in the same patients with 
various degrees of coronary atherosclerosis [7]. They found that brachial artery is an accessible 
indicator of endothelium health and the risk of coronary atherosclerosis. 
Gokce et al. determined that non-invasive detection of endothelial dysfunction in the brachial 
artery provides independent prognostic information [16]. They examined flow mediated 
dilatation (FMD) in patients who were supposed to undergo cardiac surgery up to 1 month before 
the surgery. They showed that patients with post operative events had significantly lower flow 
mediated dilatation. They concluded that endothelial dysfunction is an independent predictor of 
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post operative cardiovascular events and non-invasive assessment of endothelial function in a 
peripheral artery provides prognostic information.   
2.1.2 Smooth muscle cells (media) 
The contraction of smooth muscles is mediated through an actin-myosin sliding mechanism that 
is initiated by calcium binding to myosin. The energy of the process is provided by the 
hydrolysis of ATP. Vascular smooth muscle contraction and dilatation is responsible for blood 
volume changes and thus local pressure control. Since arteries carry the blood away from the 
heart to all the organs, they have more smooth muscle fibers within their walls. Vascular smooth 
muscle is innervated by the sympathetic nervous system. Three types of receptors (α1, α2, β2) are 
located within vascular smooth muscle cells that cause either vasodilatation or vasoconstriction.  
 
Myogenic response  
Vascular smooth muscles are responsible for the establishment of basal vascular tone and 
autoregulation of blood flow through reaction to chemical and physical stimuli. The myogenic 
response has been found in all types of vessels. It is most pronounced in arteries but it can be 
present in venules and veins. It is established that myogenic response is endothelial independent 
and depends mainly on smooth muscle cells reaction. It has been suggested that pressure-induced 
changes of vessel wall tension, and not the pressure itself, is the stimulus for myogenic response 
[14]. 
Rapid increase in transmural pressure induces an increment in vessel wall tension. Stretch 
activated cation channels on the surface of smooth muscle cells detect the increase in wall 
tension and produce membrane depolarization. Depolarization lead to calcium influx and 
initialization of actin-myosin sliding mechanisms [14, 17].      
Calcium influx following an increase in pressure was still present with the removal of the 
endothelium in a rat experience, indicating the existence of the endothelial independent pathway 
of vasoconstriction [18].  Pressure step causes the arterioles diameter to decrease and rapidly 
return to baseline diameter [17, 18]. 
Another pathway, other than physical stimulus, for vascular smooth muscle cells stimulation are 
exogenous donors of NO such as sodium nitroprusside and nitroglycerine [7, 16, 19, 20]. 
Sublingual application of nitroglycerine is widely used in myogenic response studies as an 
exogenous donor of NO that causes vasodilatation and acts directly on smooth muscle cells.  
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Anderson et al. demonstrated that coronary response to nitroglycerin was not significantly 
different between the group of patients with various degrees of coronary atherosclerosis and the 
control group [7]. Gokce et al. also observed no relationship between nitroglycerine dependent 
vasodilatation and cardiovascular events [16]. 
2.1.3 Nerve endings (adventitia) 
Adventitia is the outermost layer of blood vessels, innervated by the central nervous system 
(CNS) that is responsible for several homeostatic mechanism regulations in the human body. The 
smooth muscles cells activity is controlled via vasomotor neurofibers of the sympathetic nervous 
system (SNS). The SNS is always active at a basal tone and causes vasodilatation or 
vasoconstriction according to the organ needs. The transmitters released from nerve endings, 
such as noradrenalin and adrenaline, bind to adrenergic receptors and alter vascular basal 
contraction level. The adrenergic receptors of type α1 and α2 cause the smooth muscle cells to 
contract while the receptors of type β2 cause the muscle cells to dilate. González et al. verified 
the effect of adventitia removal on vascular function modulation. They demonstrated that 
contraction capacity of endothelium was reduced by adventitia removal [21].  Hijmering et al. 
studied the interaction between endothelium dependent vasodilatation and the sympathetic 
system using lower body negative pressure (LBNP) technique. They found the sympathetic 
stimulation could impair flow-mediated endothelial-dependent dilatation through a mechanisms 
caused by adrenergic receptors of type α [19].  They concluded that released transmitters from 
nerve endings are important modulators of endothelial function and myogenic response. 
2.1.4 Vascular tone regulation stimuli 
Vascular endothelial cells create an interface between circulating blood and vessel wall. They are 
exposed continuously to a variety of hemodynamic factors and chemical mediators. The structure 
and function of blood vessels are influenced by long term exposure to these factors.  
    
1- Shear stress  
Shear stress arises from the pulsatility of blood pressure that creates a radial velocity gradient of 
blood flow through a blood vessel. The velocity of blood particles is at its minimum at the wall 
of the blood vessels. The shear stress exerted on the vessels walls is function of the velocity 
profile slope at the wall.  
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( )
wall
dV y
dy
ητ = ⋅             (2.1)           
 
whereτ  is the shear stress, η  is the blood viscosity, ( )V y  is the velocity profile along the radial 
axis y and ( )dV y / dy represent the wall shear rate (sec-1). The blood is considered a Newtonian 
fluid with constant viscosity. In microvessels, where flow rates are relatively steady, shear stress 
could be expressed as [11, 22]: 
8wall
V
D
ητ = × ×             (2.2)           
2Flow V rπ= ×             (2.3)             
 
where V is the blood velocity and r and D are the blood vessel radius and diameter respectively. 
Shear stress is expressed in dyne/cm2. The level of wall shear stress varies in different parts of 
blood circulation. It varies from 1 to 6 dyne/cm2 in the venous system and from 10 to 70 
dyne/cm2 in the arterial system.  
The nature of shear stress exerted on endothelial cells is a function of blood flow pattern that is 
itself influenced by cardiac cycles. Therefore, endothelial cells experience a pulsatile shear stress 
with fluctuation in magnitude. Greater positive shear stress is exerted on endothelial cells surface 
while the magnitude of fluctuations increase.  
The endothelial cells, exposed to positive shear stress, reorient along the longitudinal axis of the 
vessel wall. This reorientation acts as a negative feedback helping to decrease the vessel 
resistance and the shear stress [10]. In contrast, in the areas with low mean shear stress, 
endothelial cells fail to maintain contact with each other and they would be randomly oriented. 
Malek et al. studied the effect of fluid shear stress on transformation of endothelial cells [23]. 
They showed that bovine aortic endothelial cells exposed to shear stress of approximately 15 
dyne/cm2 align in the direction of blood flow while those exposed to lower shear stress (0 – 4 
dyne/cm2) were likely to orient randomly. 
Ku et al. have measured blood flow velocity and shear stress at the human carotid bifurcation by 
laser Doppler and under pulsatile flow condition [24]. The medial wall of carotid bulb 
experiences a higher shear stress compared to the lateral wall. Their study confirmed that plaques 
tend to form more in the areas experiencing lower shear stress.  
 12
Indeed, at the sites with less shear stress, an increase in leukocytes uptake and adhesion on the 
endothelial cells surface is observable. Steady laminar shear stress causes the endothelial cells to 
release antithrombotic and antimigration agents. In contrast, reversal flow and lower shear stress 
promote the release of prothrombotic and pro-apoptosis. Moreover, it is a weaker inducer of 
NOS. In this condition the production of NO and prostacyclin decreases while the production of 
endothelin, which is an effective vasoconstrictor, increases [2, 10].  
The shear stress effect is exerted through the activation of NOS enzyme and the production of 
NO. The mechanism involves potassium channels activation as mechanosensory transducer of 
the shear stress [2, 12]. Table 2 summarizes endothelial response to hemodynamic shear stress 
based on the Malek et al. study. 
Endothelium response Shear stress > 15 dyne/cm2 Shear stress ≈ 0-4 dyne/cm2 
Vasoconstrictors 
Endothelin 
Angiotensin 
 
Low 
 
High 
Vasodilators 
NO 
Prostacyclin 
 
High 
 
Low 
Antioxidant enzymes 
(COX)-1 
 
High 
 
Low 
Inflammatory mediators 
Monocyte chemotactic 
peptide 
 
Low 
 
High 
 Thrombosis  
Low 
 
High 
Endothelial proliferation 
and apoptosis 
 
Low 
 
High 
Table 2-2: Endothelial responses to relatively high and low hemodynamic shear stress [23]. 
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Reactive hyperemia 
The creation of shear stress in accessible human blood vessels is a method for endothelial 
dysfunction evaluation. Reactive hyperemia is a transient increase in blood flow following a 
period of ischemia. The transition state at the release of ischemia induces a remarkable amount 
of shear stress on a blood vessels walls (Figure 2-4). Increases in shear stress trigger rapid 
activation of NOS. This is a widely used method to evaluate the autoregulation capacity of vessel 
endothelium to return the increased blood flow to the baseline [7, 9, 16, 25].  It has been 
established that the nature of shear stress is affected by the duration of ischemia.  Leeson et al. 
verified the relation of endothelial dependent vasodilatation and the duration of ischemia. They 
induced reactive hyperemia with cuff occlusion of 0.5, 1.5, 2.5, 3.5, 4.5 and 8 min. They found 
that 4.5 minute of cuff occlusion is required to induce a maximal vessel dilatation that arrives 
one minute after release of cuff occlusion [26]. Mullen et al. demonstrated that L-N-methyl-
Arginine (L-NMMA.), the competitive antagonist of NO synthesis, attenuated FMD after a 5 
minute occlusion time while after 15 minutes of occlusion, no effect on FMD was observed [27]. 
It indicates that 5 minute occlusion time induce an endothelial dependent vasodilatation while 
increasing the duration of ischemia results in an endothelial independent vasodilatation. Another 
study by Pyke et al. shows that by increasing the duration of shear stress, the FMD response is no 
longer NO or PGI2 dependent [11]. Therefore reactive hyperemia created by appropriate 
ischemia duration induces NO dependent vasodilatation and seems to be an appropriate physical 
stimulus to evaluate endothelial function.  
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Figure 2-4: Blood flow during reactive hyperemia, following an ischemic condition. 
  
2- Transmural pressure 
Transmural pressure is the pressure across the blood vessel walls. In many organs, the blood 
flow remains at a constant level despite big variations in blood pressure. This vascular 
autoregulation is mainly due to a pressure induced myogenic response.  It is established that in 
low pressure ranges, 10-40 mmHg, passive distention causes vessel diameters to increase. 
However, at higher transmural pressures, 60-100 mmHg, active myogenic response results in 
vessel diameter decrease and vasoconstriction [14]. The sensors that detect the variations of wall 
tension are stretch activated cation channels. Their activation results in smooth muscle cells 
membrane depolarization and an increase in calcium influx. Therefore, a steep increase in 
transmural pressure from 0 to mean arterial pressure, which is the case at the onset of reactive 
hyperemia, causes an increase in vessel diameter followed by a decrease in diameter due to 
myogenic response.   
 
3- Agonist agents  
There are agonist mediators other than physical stimulus that induce a vasodilatation response. 
ACh, bradykinin or substance P are endogenous donors of NO that bind to specific receptors on 
the endothelial cells surface and cause the release of vasodilatory agents such as NO, EDHF and 
prostacyclin.   
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Nitroglycerine and sodium nitroprusside are exogenous donor of NO. They convert to NO in the 
body and they bypass the effect of endothelial cells, thereby inducing direct vasodilatation. 
Injection of acetylcholine in the arterial vessels and sublingual use of nitroglycerine are widely 
used methods to evaluate endothelial-dependent and endothelial-independent vasodilatation 
responses respectively [7]. Eskurza et al. demonstrated that there was a poor correlation between 
ACh-mediated vasodilatation and shear stress mediated vasodilatation indicating that they 
provide different information on the endothelial function [28].  It seems that ACh triggers the 
release of EDHF rather than EDRF (such as NO).  
 
2.1.5 Atherosclerosis and endothelial dysfunction  
Atherosclerosis is a chronic inflammatory disease. Atherosclerotic lesions occur principally in 
elastic and muscular arteries. They develop when low density lipoprotein (LDL) molecules 
becomes oxidized by oxygen free radicals, which are highly present in arterial blood vessels. The 
immune system tries to repair the damage created by LDL, by sending leukocytes to the 
damaged location. However, macrophage blood cells are not able to absorb LDL and they cause 
extra amount of LDL and leukocyte accumulation within the arterial intima. This process leads 
to cholesterol plaque creation, remodeling of the artery, decreases of blood flow and shear stress 
(Figure 2-5).  
Accumulation of oxidized LDL in vessel wall results in production of reactive oxygen species. 
These species are able to rapidly inactivate the production of NO.  Most cardiovascular risk 
factors such as hypercholesterolemia, smoking and hypertension are associated with an increase 
in oxidative agents, damaging endothelial cells and reduced NO bioactivity [29].   
Another important factor in initiation of atherosclerotic lesions is low levels of shear stress at 
blood vessel wall. The shape and orientation of endothelial cells is influenced by blood flow and 
shear stress at both intracellular and ultra structural levels. The most important structural 
manifestation of endothelial cells is their alignment in the blood flow direction. The F-actin 
filaments are band shaped microfilaments around the periphery of endothelial cells, which are 
called stress fibers. They are quite important to endothelial cells as they control cells adhesion 
and shape maintenance. In the region with high levels of shear stress, the stress fibers are aligned 
with those of neighboring cells. This alignment acts like a single large microfilament extended 
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on the adjacent endothelial cells able to distribute the shear stress throughout the cells, thereby 
limiting endothelial cells deformation. These microfilament bundles increase in number when the 
endothelial cells are exposed to relatively high level of shear stresses. However, in the sites with 
lower levels of shear stress due to decreased blood flow, endothelial cells adopt a relatively 
random shape and orientation and show an increase uptake of lipoproteins and leukocytes 
adhesions on the surface [10, 30]. 
Uematsu et al. demonstrated a positive correlation between wall shear stress and the extent of 
microfilament bundle distributions [31]. Their study suggests that low levels of shear stress 
decrease the formation of microfilament bundles leading to initiation of atherosclerosis.  
 
 
Figure 2-5: Stages of endothelial dysfunction in atherosclerosis. 
 
It is established that endothelial dysfunction is present at very early stages of atherosclerosis and 
before the disease becomes symptomatic.  
 
2.2 Quantification of endothelial function and blood flow measurement 
Reduced bioactivity of NO and enhanced activity of vasoconstrictor agents, in presence of 
atherosclerotic risk factor, are the main reasons for impaired vasodilator capacity of blood 
vessels. Vasodilator capacity of endothelial cells could be assessed by measurement of cells 
response to physical or chemical stimulation that trigger endothelium activation. Endothelium 
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activation in a healthy vascular system ends up with release of vasodilator agents such as NO and 
prostacyclin. However, in the presence of atherosclerosis risk factors or an established coronary 
heart disease, endothelial cells fail to normally respond to an increase in shear stress or 
endothelial receptors stimulation through releasing relaxing factors.  
Several studies have been developed to evaluate endothelial function in patients at high risk for 
atherosclerosis as well as in patients with already established atherosclerotic disease. A number 
of invasive and non-invasive methods have been developed. The stimulation of endothelial cells 
is performed through:  
- Agonist receptors stimulation by intra arterial infusion of nitric oxide; 
- Shear stress elevation on blood vessel wall through creation of reactive hyperemia. 
Vasodilator effect of endothelium on blood vessel wall is evaluated through: 
- Measurement of blood flow variations; 
- Measurement of flow mediated dilatation (FMD); 
- Imaging techniques. 
   
2.2.1 Non-invasive developed methods 
In actual clinical situations, coronary endothelial function is assessed using coronary 
angiography by measuring vasomotor responses to an intra arterial infusion of ACh. However, 
arterial catheterization limits clinical application of this method in patients with low incident of 
coronary arterial diseases. Therefore applicable non-invasive methods in patients without known 
coronary artery seem to be essential in clinical situation. A number of non-invasive techniques 
with comparable results to invasive methods have been developed. In this section, various non-
invasive methods of assessing endothelial function with peripheral arterial vasomotor responses 
are described.  
 
2.2.1.1 Strain gauge plethysmography (SGP) 
Plethysmography is a method to measure volume changes within an organ. Strain gauge 
plethysmography involves measuring blood volume changes of a limb using a strain gauge. This 
is an extensively used and accepted method to quantify endothelial function non-invasively, 
through blood flow measurement [8]. A strain gauge is a stretchable silicone tube containing a 
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liquid metal such as mercury. The principle of blood volume measurement is based on the theory 
that the electrical resistance of the mercury filled silicone is directly proportional to its length 
which varies as forearm circumference change as a response to limb blood volume variations.  
Venous outflow is periodically halted and restarted through an inflatable cuff positioned on the 
upper limb. The cuff is inflated to 50 mmHg to prevent venous outflow without affecting arterial 
inflow. Consequently the limb swells as the arterial inflow accumulates in venous reservoir and 
results in an increase of limb volume during cuff inflation. Changes in limb volume are 
detectable via stain gauges that are placed on the limb. The upslope values of limb volume 
increase during cuff occlusions and are proportional to the arterial inflow (Figure 2-6). 
 
Figure 2-6: Strain gauge plethysmography. 
 
In many reactive hyperemia studies, this technique is used to measure forearm blood flow since 
it is considered a gold standard method [25]. Measurements are based on the assumption that 
increment in forearm volume is directly related to limb blood flow. The method is simple and 
inexpensive which makes its usage feasible for clinical applications. However, it does not 
provide regional information and should be recorded only in static situation since the technique 
is very sensitive to any movement of the limb. Therefore, the application of the method in blood 
flow measurements in dynamic conditions is limited.  
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2.2.1.2 Near infrared spectroscopy (NIRS) 
Near infrared spectroscopy is the measurement of near infrared light (800-2500 nm) intensity 
and wavelength, absorbed by a sample such as human tissue.  NIR light can penetrate relatively 
far into a sample (up to 6 cm in muscle). Biological tissue is a weak absorber and relatively 
strong scatterer of NIR light. The absorbed and transmitted light through human tissue contains 
information about sensitive chromophores (compounds which absorb light in the spectral region 
of interest) such as hemoglobin and myoglobin molecules, thus permitting the study of physical 
changes over time.  
Each chromophore has its own particular absorption spectrum which describes the level of 
absorption at each wavelength (Figure 2-7).  
 
Figure 2-7: Molar absorption coefficients of oxy- and deoxy-hemoglobin 
in near-infrared region measured by Yamashita et al. [32]. 
 
Wavelengths within the near infrared region seem to be suitable for the measurement of 
hemoglobin due to their relatively deep penetration. The wavelength region of 750 – 850 nm is 
widely used for non-invasive measurement of oxy and deoxy hemoglobin concentration since the 
two spectra intersect around a wavelength of 805 nm that provides a measurement independent 
of the degree of hemoglobin oxygenation allowing total hemoglobin concentration measurement 
[32]. The variations in the total hemoglobin reflect variations in the blood volume. Therefore, 
blood flow can be calculated by relative changes of total hemoglobin from the baseline at a given 
time.  NIRS monitors oxygen as a tracer.  
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The principle of measurement 
The relation between light absorption and chromophore concentration in a non scattering 
medium is described by Beer Lambert law: 
0
log IA d
I
cα⎛ ⎞= = ⋅ ⋅⎜ ⎟⎝ ⎠             (2.4)           
where A is light attenuation, I and I0 are incident and transmitted light intensities respectively, α 
is the absorption coefficient, c is the chromophore concentration and d is the distance that light 
travels through the sample (physical distance between light emitter and detector). However, in a 
scattering medium such as biological tissue, light do not travel in a direct path and thus light 
attenuation is a complex function of tissue geometry, absorption and scattering coefficients. 
Therefore, the modified Beer Lambert law is expressed to take these variables into account: 
0
log IA L G
I
cα ⋅⎛ ⎞= = ⋅⎜ ⎟⎝ ⎠
+             (2.5)          
 
where L is the actual light pathlength which is not straight due to scattering (L>d), G is the light 
attenuation due to scattering that is an unknown parameter. Because of the later factor (G), the 
equation can not be solved to yield an absolute concentration of the chromophore. However, if G 
is considered as a constant parameter in terms of time, it is possible to measure relative 
variations of the chromophore concentration, oxy and deoxy hemoglobin (Figure 2-8).  
A L cα ⋅Δ = ⋅ Δ             (2.6)                                 
Changes in C can be calculated relative to a starting point considered as zero. 
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Figure 2-8: Light pathlength in a non scattering (a) and a scattering (b) medium. 
 
The differential pathlength factor (DPF), which indicates light pathlength through tissue is 
measured by time resolved spectrometry method that is based on the measurement of time of 
ultrasound pulses flight through a tissue.  
c tL
n
⋅
=             (2.7)                 
where c is sound speed and n is refractive index of tissue. 
The modified Beer Lambert law is used for the measurement of relative variations in oxy and 
deoxy hemoglobin. The variations in total hemoglobin concentration correlate with variations in 
total blood volume, an assumption required for the measurement of blood flow [33].   
NIRS probes have a special optical design. The emission probe radiates laser beams in NIR 
region and the detection probe detects attenuated light that has passed through the tissue of 
interest.  The emission probe is made of fiber optics and the detection probe is a photodiode 
sensor (light to current converter) which is placed some centimeters apart from the emission 
probe. The emitted light illuminates the tissue in a ‘banana-shaped’ distribution providing 
information from relatively deep tissue layers. In human oxygenation measurements, the 
detection probe is usually placed on the same side and not on the opposite side. In this particular 
case, it detects a part of the diffused and reflected light (Figure 2-9).  
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Figure 2-9: Forearm near infrared spectroscopy. 
 
The distance between emitter and detector is a compromise between received light intensity and 
deeper light traveling. In fact when the emitter-detector separation increases, the detected light 
intensity decreases while it carries more information from deeper layers of tissue. Therefore, 
specific emitter-detector separation provides information from specific layer of the tissue of 
interest. This separation is usually chosen to be between 2 and 3 cm [34, 35].  
Yu et al. studied the dynamics of muscle blood flow during reactive hyperemia using NIRS [36]. 
They tried different source-detector separation configurations. They found that increase in 
source-detector separation causes an increase in blood flow and blood oxygen saturation 
overshoots following cuff occlusion while oxygen saturation undershoot during ischemia 
decreased.  
Wariar et al. constructed a modular NIRS system for clinical measurement of impaired skeletal 
muscle [37].  Their system design leads to an understanding of the basis of an NIRS system.  
Elements of their systems are showed as a block diagram in Figure 2-10.  
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Figure 2-10: The instrument design of a modular NIRS system by Wariar et al.  
BPF represents band-pass filter  [37]. 
 
They calculated variations in optical absorption at each wavelength from the logarithm of the 
measured output voltages ratio: 
( ) ( ) ( )log log o darko dark
b dark
V t V
A t V V
V V
−
Δ = −Δ − = −
−
            (2.8)         
where Vdark is voltage output without any illumination source and Vb is voltage of forearm at rest 
before any occlusion or activity. Changes in absorption are then converted to changes in 
concentration of oxy- and deoxy- hemoglobin.  
A dcλ λαΔ = ⋅Δ ⋅∑             (2.9)        
 
2.2.1.3 Other methods  
Pulsed Doppler Ultrasound 
This echography approach provides both blood vessel image and the velocity of the blood in the 
artery. Volume blood flow can be measured in deep abdominal vessels using this technique [38, 
39]. The technique is based on the Doppler effect which corresponds to an alteration in sound 
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wave frequency resulting from the motion of red blood cells. The velocity of red blood cells is 
given by: 
max
2 cos
f cV
f θ
Δ ⋅
=
× ⋅
            (2.10)         
where f is the transmitted frequency, c is the sound speed and θ is the angle between the sound 
beam and the blood flow direction. The volume flow rate is calculated by: 
Flow V A= ⋅             (2.11)               
where V is the mean velocity and A is the cross-sectional area of the blood vessel determined 
from the ultrasonic image of the blood vessel. The penetration depth of ultrasound waves is a 
function of incident wave frequency. For example, 8 MHz probe provides penetration depth of 4 
cm for ultrasound wave. Therefore, superficial structures are imaged at a higher frequency (8-18 
MHz) while deeper structures are imaged at a lower frequency (1-7 MHz).  
Shear stress and flow mediated dilatation (FMD) that describes the vasodilatory response of a 
vessel to blood flow elevations are measured using the ultrasound image of the vessel as 
following: 
( )% DF BL
BL
D DFMD
D
−
=             (2.12)           
8
BL
VSS
D
μ= × ×             (2.13)                 
where DBL and DDF represent brachial artery diameters at baseline and post-deflation phases 
respectively, SS represents shear stress, V is blood flow velocity and µ is blood viscosity. The 
technique provides flow changes measurement in deeper tissue layers. However, it is not 
sensitive to blood flow in small vessels such as capillaries and arterioles and it does not provide 
continuous measurement.  
 
Laser Doppler 
This is a non-invasive technique for measurement of red blood cells perfusion in tissue [40]. A 
percentage of light beam incident in tissue is scattered by moving red blood cells that results in a 
frequency shift of the light. The light which is backscattered by red blood cells, as well as by 
static tissue, is detected by a photodetector. The emitted and returned light are then compared to 
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extract the Doppler shift caused by moving red blood cells. The Doppler shift is proportional to 
the flux of red blood cells. 
The technique provides a continuous recording at the region of interest. However, it is only able 
to measure flow changes at the surface level since the penetration depth of the laser beam is no 
greater than 500 μm [41].  
 
Magnetic resonance imaging (MRI) 
MRI is an extremely versatile technique that provides anatomical and functional information on 
a body region of interest. The technique has wide applications in quantitative assessment of 
blood flow and blood oxygenation [42, 43]. Oxygenated and deoxygenated hemoglobin are 
diamagnetic (negative magnetic susceptibility) and paramagnetic (positive magnetic 
susceptibility) respectively. Increase in blood flow is accompanied with an oxy-hemoglobin 
concentration increase and a deoxy-hemoglobin concentration decrease. Therefore, the magnetic 
susceptibility decreases resulting in MRI signal intensity enhance. 
The technique provides high temporal and spatial resolution images. However, the large size and 
high cost of MRI systems restrict their clinical applicability in reactive hyperemia studies.  
 
Positron emission tomography (PET) 
PET is a nuclear medicine imaging technique which provides a map of metabolic process in the 
body that allows the study of biochemical changes in terms of time. The technique is used for 
assessment of blood flow in peripheral vascular disease. After intravenous bolus injection of 15O-
water (H215O) radioactive molecules, a dynamic PET scan is acquired. Time-activity curves in 
blood and tissue reflect different regional blood flow [44]. Compared to MRI, the technique 
provides poor spatial and temporal resolution while it is also costly.   
 
Radionuclide plethysmography 
Radionuclide plethysmography is a recently developed and validated method by Harel et al. in 
the nuclear department of Montreal Heart Institute [45, 46]. Radionuclide plethysmography uses 
gamma detector probes to detect radioactivity variation during repeated venous occlusions. The 
method uses technetium-99m (99mTc) labeled autologous red blood cells as radioactive tracers to 
measure the radioactivity variations.  The 99mTc compound with red blood cells can be used to 
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map circulating blood in an organ such as the forearm.  Measurements performed with this 
method were highly correlated with those performed with SGP. However, intra arterial injection 
of a radioactive tracer is needed.  
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Chapter 3: Methodologies 
We designed two experiments to test our hypotheses. The first experiment (Experiment1) was 
designed to test the ability of NIRS to measure blood flow variations in the forearm during 
reactive hyperemia. The second experiment (Experiment2) was designed to characterize the 
contribution of endothelium in vascular tone regulation during reactive hyperemia. 
Instrumentation, protocol designs and setup as well as the method of blood flow calculation that 
are common to both experiments are described in sections 3.1 to 3.4. Analyses that are specific 
to each experiment are described in sections 3.5 and 3.6. 
 
3.1 Instrumentation 
Figure 3-1 shows the schematic of all instruments including a strain gauge plethysmograph 
system, an NIRS system, an occlusion system, an electrocardiograph, an A/D converter and a 
computer. 
 
Figure 3-1: Schematic of two measurement modality systems. 
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3.1.1 Oxygenation monitor (NIRO-200) 
The Niro-200 is a tissue oxygenation monitor based on near infrared spectroscopy. It provides 
continuous, non-invasive and real-time measurement of tissue oxygenation with a sampling rate 
of 6 Hz. The device is useful in clinical studies such as metabolism and function of brain as well 
as the study of muscle tissue oxygenation. Niro-200 is a two-channel oxygenation monitor 
allowing simultaneous measurement at two sites. It provides six parameters: 
 
- Changes of oxygenated hemoglobin 2( )O HbΔ  
- Changes of deoxygenated hemoglobin ( )HHbΔ  
- Changes of total hemoglobin ( )cHbΔ  
2( ) ( ) ( )cHb t HHB t O Hb tΔ = Δ + Δ              (3.1)           
- Ratio of oxygenated to total hemoglobin in percentage ( )TOI  
2 ( )( ) 100
( )
O Hb tTOI t
cHb t
= ×             (3.2)                   
- Relative value of total hemoglobin ( )THI  
( ) ( )THI t k cHb t= ×             (3.3)                         
k: a constant that is determined by the light scattering property in the measured tissue  
 
- Normalized THI by the initial value ( )nTHI  
( )( )
(0)
THI tnTHI t
THI
=             (3.4)                          
 
The light source is a pulsed laser diode with a pulse duration of approximately 200 ns and a 
frequency of 2.7 kHz. The detection probe is a photodiode. Optical fiber bundles transfer the 
light produced by the light source to the emission probe and a multiwired shielded cable carries 
back the detected light to the device for analysis.  
 
Measurement principle 
The modified Beer Lambert law is used for the measurement of 2O HbΔ , HHbΔ and cHbΔ . The 
light attenuation variations at three wavelengths (775, 810, 850 nm) are calculated for 
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measurement of three unknown parameters: 2O HbΔ , HHbΔ  and pathlength (L). In fact the 
calculation of the three parameters is based on light attenuation in terms of time. 
 
( ) ( )
( ) ( )
( ) ( )
1 2
2 2
3 2
( ) [ 1,1 2,1 ]
( ) [ 1,2 2,2 ]
( ) [ 1,3 2,3 ]
A L a O Hb a HHb
A L a O Hb a HHb
A L a O Hb a HHb
λ
λ
λ
Δ = × × Δ + × Δ
Δ = × × Δ + ×Δ
Δ = × × Δ + × Δ
             (3.5)                        
 
where ( , )a i j  represents molar extinction coefficient of HHb and O2Hb (i=1, 2) at wavelengths 
(λ1, λ2 and λ3). If the pathlength is known in the above equations, 2O HbΔ and HHbΔ  are 
calculated as absolute concentration changes (Δμmol). It seems to be established that if physical 
distance between emitter and detector (d) is more that 3 cm, the pathlength is proportional to the 
distance by a constant called differential pathlength factor (DPF). 
 
L DPF d= ×              (3.6)                                     
 
The NIRO-200 operation manual provides typical DPF values for different parts of the body 
such as the forehead, the forearm and the calf in males and females. Since the value of physical 
distance (d), between detector and emitter for Niro-200 is 4 cm, it is possible to estimate the 
pathlength and input it into the device setting function. 
 
( ) 3.59 4 14.36L forearm cm cm= × =  
 
TOI and THI are measured using spatially resolved spectroscopy method. In this method, light 
attenuation is measured along distance ( )A ρ∂ ∂ . The Niro-200 employs a two segment 
photodiode chip to measure light attenuation along the distance between the two segments 
(Figure 3-2).  
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Figure 3-2: Niro-200 emission and two-segment detection probe. 
 
The value of A ρ∂ ∂  is calculated at three wavelengths by an equation derived from the photon 
diffusion principle. 
 
( ) ( )
( ) ( )
( ) ( )
2
2
2
( 1) 2{ 1,1 1,2 }
( 2) 2{ 1,2 2,2 }
( 3) 2{ 1,3 3,2 }
A k a O Hb a HHb
d
A k a O Hb a HHb
d
A k a O Hb a HHb
d
λ
ρ
λ
ρ
λ
ρ
∂
= ⋅ × + × +
∂
∂
= ⋅ × + × +
∂
∂
= ⋅ × + × +
∂
            (3.7)                
where k is the unknown parameter determined by light scattering properties. 
 
Light pathlength 
Adequate infrared light penetration into tissue is an important issue. The depth of light 
penetration depends on optical tissue properties as well as source-detector separation. The 
muscle layer lies generally under the skin and adipose tissue (upper layer). The thickness of the 
upper layer is in the order of a few millimeters. 
It has been established that signal from short source-detector separation (0.5-1 cm) are derived 
mainly from upper layers whereas signals detected from detector separated more than 2 cm from 
the source are mostly due to the muscle layer [36]. However, there is always a contribution from 
the upper layers to the detected signal. The distance between the Niro-200 emission and 
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detection probes (4 cm) seems to be sufficient to make the infrared light travels deep enough in 
the tissue to remove the contamination from the superficial layer.  
 
3.1.2 Strain gauge plethysmograph  
A venous occlusion plethysmograph system consists of the following parts: 
- Limb strain gauge 
- Plethysmograph 
- Rapid cuff inflator 
- Cuff inflator air source 
- Pressure cuffs 
  
In our experiments, strain gauge plethysmography was performed using a dual-channel 
plethysmograph (Hokanson EC-4, D.E. Hokanson Inc). The plethysmograph is able to detect 
very small changes in limb volume, providing precise monitoring of forearm blood volume 
variations. On the other hand, its sensitivity makes the signals vulnerable to artifacts. The analog 
output of the plethysmograph is transferred to a PC via an analog to digital (A/D) converter. 
 
Different forearm gauge sizes from 16 to 32 cm are available to accommodate the patient’s 
forearm size. The gauges are placed on the forearm 5 cm below the elbow. They have double 
rubber loops, filled with mercury that wrap in parallel around the limb. As the volume of the 
limb changes, the gauge tube is stretched and the electrical resistance varies proportionally to the 
volume size. Resistive variations are processed and displayed as waveforms expressed in mL·dL-
1·min-1  
 
The Hokanson E20 rapid cuff inflation system was used to inflate the pressure cuffs, used for 
venous and arterial occlusions.  It can inflate and deflate the vascular cuff in less than 0.3 
seconds over a range of 0 to 300 mmHg as well as maintaining the pressure for as long as the 
protocol requires. The E20 digital readout displays cuff pressures within 1 mmHg over a range of 
0 to 300 mmHg. The E20 requires a source of pressurized air provided by the Hokanson AG101.  
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3.1.3 Electrocardiograph (AccuSync) 
A 3 lead ECG trigger monitor (AccuSync 7, Medical Research Corporation, Milford) displays 
the ECG of the patient and automatically detects the R waves. The ECG signal and R triggers are 
recorded on the computer for further analysis of a patient’s cardiac rhythm variation during the 
experience.  
   
3.1.4 Analog to digital converter (ADC) and RS232 
The SGP and ECG signals are transferred to the computer via an A/D device (Dataq, model DI-
148U, DATAQ Instruments, Inc., Akron, Ohio) at 250 Hz. The 8 channel ADC power is derived 
from the PC through the USB interface. The voltage resolution of the converter is ±19.5 mV (10 
bits) with a full scale measurement range of -10 to +10 volts. The maximum sampling frequency 
of the ADC is 14,400 Hz. In addition, the NIRS signal is transferred to the computer via an 
RS232 port.  
 
3.2 Protocol design 
In both experiments, the protocol included three consecutive stages (Figure 3-3). 
- Baseline or pre-ischemic period (3 min), 
- Ischemic period (5 min), 
- Reactive hyperemia or post-ischemic period (7 min).  
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Figure 3-3: Study protocol timeline (SP represents systolic pressure). 
 
The blood flow measurements were made by successive cycles of venous occlusion and release 
during the experiment. At the baseline, flow measurements were performed with 20 seconds 
occlusion-deflation cycles (10 sec occlusion time followed by a 10 sec deflation time). The 
pressure was applied through a pressure cuff (venous cuff) connected to the pneumatic cuff 
inflator. Nine measurements were obtained during 3 minutes of pre-ischemic period. 
 
After this period, a suprasystolic pressure was applied through another cuff (arterial cuff), on the 
left arm for 5 minutes to halt forearm blood circulation. During the ischemia period, 15 flow 
measurements were obtained. After 5 minutes of ischemia, arterial cuff was released to evoke 
hyperemic response on the left forearm. Successive cycles of venous cuff occlusion-deflation 
were decreased to 10 seconds for the first 2 minutes post-ischemic to obtain a higher temporal 
resolution. During the post ischemic period, 27 inflation-deflation cycles were performed 
resulting in 27 flow measurements. 
 
3.3 Experiments setup 
The experiment was carried out in a quiet room with a temperature of 24º C. Patients sat in 
supine position on a recliner chair with arms prone and above heart level in order to facilitate the 
venous outflow.  Venous cuffs were placed around distal parts of left and right upper arms to 
 34
perform repetitive venous occlusions. Both cuffs were connected to a pneumatic cuff inflator set 
to 50 mmHg. This cuff pressure is sufficient to occlude completely the venous outflow  without 
affecting arterial inflow [47].   
 
 
Figure 3-4: Cuffs position on patient arms during the experiment. 
 
The Arterial cuff was placed on the proximal part of the left upper arm (Figure 3-4). The cuff 
was inflated to a pressure of 50 mmHg above systolic pressure. The duration of arterial occlusion 
is an important issue for inducing maximum endothelial cells stimulation and as a result, vessel 
dilatation. It has been shown that maximum arterial response is reached after 4.5 min of 
occlusion [26]. Occlusion cuff position is also an important determinant of the magnitude of 
brachial artery flow-mediated dilatation. It seems to be established that upper arm cuff placement 
yields greater hyperemic response compared to wrist cuff placement [48, 49]. Therefore, upper 
arm occlusion is more suitable for detection of subtle differences between groups of patients. 
  
Strain gauges were placed around the largest part of the left and right forearms (about 5 cm 
below the elbow crease) and were connected to the plethysmograph. NIRS sensors were placed 
on the anterior parts of the left and right forearms adjacent to the strain gauge in a longitudinal 
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orientation and at approximately the same distance from elbows. They have auto-adhesive 
surface to hold firmly on the forearm skin and preventing any displacement (Figure 3-5). 
 
The electrocardiogram (ECG) was recorded using 3 leads throughout the experiment to detect 
any cardiac cycle variations during different phases of the experience.   
 
Figure 3-5: NIRS probe and strain gauge positions. 
 
All signals including blood volume variations in mL/100mL/min by SGP, total hemoglobin 
variations in μmol/L by NIRS and electrocardiograph with time based control codes were 
recorded on a personal computer by a custom acquisition program designed with the MATLAB
® 
programming language (Figure 3-6). For an online signal quality monitoring, the signals were 
plotted in real time throughout the experiment. 
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Figure 3-6: Acquisition interface. 
   
3.4 Blood flow measurement 
The increase in blood volume generated by the application of repeated venous occlusions, allows 
the computation of the arterial inflow. It is defined as: 
( )d Volumeflow
dt
=              (3.8)           
 
The arterial inflow was calculated for each venous occlusion by computing the upslope value on 
the ascending part of blood volume variations. Repetitive venous cuff inflation and deflation 
caused slight movements of forearms all throughout the experience. These movements affect 
SGP signal through sharp rises at the onset of cuff inflation (cuff jump). In order to avoid blood 
flow overestimation, we excluded the first 2 sec of SGP signal from upslope calculation. We 
applied a linear regression model on the next 3 seconds period of the signal to calculate the rate 
of blood volume increase at the onset of each venous occlusion (Figure 3-7). Although the 
NIRSP signal was almost unaffected by the mentioned artifact, we considered the same period of 
time as SGP for the flow measurement.   
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Figure 3-7: Linear regression application for calculation of arterial inflow with NIRS. 
 
The SGP measures blood relative volume variations in limbs (in mL of blood/100mL of tissue). 
The application of linear regression provides the rate of relative blood volume variations thus the 
arterial inflow in mL·100mL-1·min -1. 
  
By NIRSP, we are able to indirectly measure arterial inflow. The NIRS device provides total 
hemoglobin variations in μmol/L, which is proportional to blood volume variations. Upslopes 
were calculated using a linear regression model. Therefore, we obtained arterial inflows in 
μmol/L/min. In order to provide arterial inflow measurements in the same units as SGP 
(mL/100mL/min), we applied a calibration factor on the flow measures by NIRSP. A linear 
regression between blood flow measurements during reactive hyperemia, by SGP in 
mL/100mL/min and NIRS in μmol/L/min was performed.  The Slopes of the regression fit was 
used as the calibration factor. 
 
3.5 Experiment1 
3.5.1 Subjects 
After the protocol approval by the research and ethics committees of the Montreal Heart 
Institute, 13 healthy volunteers with a low likelihood of coronary artery disease (CAD) were 
recruited for the experiment (Table 3-1) [50].  
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Gender 5 men / 8 women 
Age 40 ± 14 
BMI 28.2 ± 3.8 kg/m² 
Active smoker n=1  
Patients 
condition 
High blood pressure n=1 
Table 3-1: Patient population characteristics for experiment1. 
 
3.5.2 Protocol 
The protocol of the experience was the same as the previous study described in 3.1.  
 
3.5.3 Setup 
SGP and NIRSP measurements were performed simultaneously during the experiment and the 
experiment setup was the same as described in 3.2.  
 
3.5.4 Statistical analysis 
Statistical analysis was performed using the SPSS statistical package version 10.0 and GraphPad 
Prism version 5.01. We evaluated the repeatability of measurements at baseline through intra-
class correlation coefficient (ICC) at baseline level for each modality. Nine measurements were 
made during baseline period. To understand the relation between forearm blood flow 
measurements during reactive hyperemia, we performed a linear regression. Bland-Altman plot 
allowed the verification of the agreement between the two methods. We used repeated ANOVA 
test to verify the existence of a significant difference between the two modalities during reactive 
hyperemia. Statistical significance was accepted when the two-tailed p value was <0.05. 
3.6 Experiment2 
We found a good correlation between flow measurements by NIRSP and SGP [51].  Blood flow 
measurements during reactive hyperemia allowed to isolate the flow mediated dilatation 
following an acute increase in blood flow. We were interested in studying the integrity of the 
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endothelium using blood flow variations measured by NIRSP during reactive hyperemia (Figure 
3-8).  
 
 
Figure 3-8: Blood flow variation during RH measured by NIRSP. 
 
During ischemic period, the vascular impedance decreases markedly. This period is accompanied 
by a shortage of oxygen, arteries dilatation and a buildup of vasodilator metabolites. By releasing 
the arterial cuff, blood flow increases instantly and perfusion pressure is restored. The increase in 
blood flow washes the accumulated vasodilator metabolites away while inducing a remarkable 
amount of shear stress on vessel wall.  
Sudden increase in vessel wall tension along with vasodilator metabolites washout, make the 
vascular muscle contract immediately after arterial cuff release. On the other hand, the sudden 
increase in blood flow elicits the release of endothelium derived dilator factors that may limit 
myogenic constriction thereby, reducing the enhanced level of shear stress on vessel walls. 
Consequently, tissue becomes re-oxygenated, vessels regain their normal vascular tone and 
blood flow returns to baseline (Figure 3-9). Therefore, the integrity of endothelial cells has an 
important effect on vascular tone retrieval.    
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Figure 3-9: Vasoactivation steps during three stages of the experiment. 
 
Blood flow measurements during the three steps of our protocol allowed following the variations 
in forearm vascular tone (Figure 3-10).  
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Figure 3-10: Blood flow measurement by NIRSP at three stages of study: pre-ischemic, ischemic 
and post-ischemic period. 
 
The forearm blood flow plot during reactive hyperemia generally exhibited a bimodal form: the 
first peak occurred exactly after the release of arterial cuff while the second one arrived 
approximately 52 to 60 seconds later. The amplitude of the second one was smaller compared to 
the first one (Figure 3-8). We hypothesized that the peaks might be related to different 
mechanisms of endothelial dependent and independent vasoactivation. We attributed the first 
peak to myogenic response, which is endothelial independent, and the second one to endothelial 
dependent vasodilatation. 
 
We based our assumptions on the fact that transition state at the release of ischemia is 
accompanied by sudden increase in blood flow and vascular pressure [14, 17, 18]. Increase in 
pressure elicits vascular muscles contraction that limits blood flow immediately; this event forms 
the first peak on blood flow plot during reactive hyperemia.  Increase in blood flow at the onset 
of reactive hyperemia phase elicits the release of relaxing factors (NO) from endothelial cells [2, 
12]. NO makes the vessels dilate and limits myogenic contraction. Maximal dilatation due to the 
release of NO occurs approximately one minute after arterial cuff deflation that forms the second 
peak [7, 26, 37]. 
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Based on our hypothesis, we defined an index to quantify the capacity of vascular endothelial 
cells in releasing endogenous NO in comparison with the amount of stimuli on vessel wall. This 
factor could be compared among different subjects. We fitted a gamma variate function to each 
of the detected peaks during reactive hyperemia. We defined the following equation: 
2
1
( )
( )
AUC Gammafactor
AUC Gamma
η =               (3.9) 
 
where AUC represents the area under curve and Gamma1 and Gamma2 represent the first and 
second gamma variate functions respectively. The aim of this study is to verify the repeatability 
of the ηfactor in the same subject after 3 and 24 hours. It has been established that most of the 
mechanical stress responses in endothelial cells disappear in 3 hours. However, there are still 
some effects such as cell surface stiffness and regulation of fibronectin synthesis, which remain 
up to 24 hours [15] (Table 1).  
3.6.1 Subjects 
After approval of the measurement protocol by the research and ethics committees of the 
Montreal Heart Institute, 15 healthy volunteers with low likelihood of CAD were recruited for 
the experiment (Table 3-2) [50].  
 
Gender 6 men / 9 women 
Age 37 ± 10 
BMI 24.63 ± 5.55 kg/m² 
Active smoker n=1  
Patients 
condition 
High blood pressure n=2 
Table 3-2: Patient population characteristics for experiment2. 
 
3.6.2 Protocol 
The protocol of the experience was the same as the previous study described in 3.2. We executed 
the same protocol three times on each subject, the second experiment was carried out 24 hours 
after the first one. The third experiment was performed 3 hours after the second one (27 hours 
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after the first experiment). In all three experiments, subjects were fasten to avoid probable effects 
of nutrients on vasodilatory mechanism of endothelial cells [52].  
3.6.3 Setup 
SGP and NIRS measurements were performed simultaneously with the same setup as the 
previous study described in 3.2. Studies began at 8:30 A.M. after a 12 hour fasting period. The 
experience was repeated twice the day after at 8:30 A.M., after a 12 hour fasting period, and at 
11:30 after a 15 hour fasting period.  
 
3.6.4 Data analysis 
Gamma variate function fitting was based on a simplified formulation presented by Madsen et al 
[53].  They represent a function depending on four parameters among which there is no coupling. 
The gamma variate function with four independent parameters, ymax, xmax, x0 and α is expressed 
as: 
 
0
max 0
1 ( )
0
max
max 0
x x
x xx xy y ex x
α
α ⎛ ⎞− −⎜ ⎟
−⎝ ⎠⎛ ⎞ ×⎜ ⎟⎜ ⎟⎝ ⎠
−
=
−
        (3.10) 
 
A gamma variate function, with appropriate initial points was applied to the first part of the 
signal, including the first peak. Subtraction of the first gamma fit from the original blood flow 
curve yielded the second part, including the second peak. For a second time, a gamma variate 
function with appropriate initial points was fitted to the second part (Figure 3-11). We calculated 
the area under the curves for the two gamma functions and their ratio represented the ηfactor.    
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Figure 3-11: Gamma variate function fitting on the first and second detected peaks. 
 
3.6.5 Statistical analysis 
Statistical analysis was performed using the SPSS statistical package version 10.0 and GraphPad 
Prism version 5.01. We evaluated the repeatability of calculated ηfactor at 3h and 24h 
experiments through intra-class correlation coefficient. Linear regression was performed between 
the calculated ηfactors from the 3h and 24h experiments. We used repeated ANOVA test to 
verify the existence of a significant difference among the three repeated experiments. Statistical 
significance was accepted when the two-tailed p value was <0.05. 
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Chapter 4: Results 
4.1 NIRS method vs. gold standard (SGP) 
Repeatability 
The repeatability of blood flow measurements at baseline for SGP and NIRSP were assessed 
using intra-class correlation coefficients (ICC). In this regard, nine resting baseline flow 
measurements were made at baseline. Left arm baseline blood flow was 3.36 ± 1.35 
mL/100mL/min and 3.90 ± 1.74 mL/100mL/min for SGP and NIRS respectively (p= 0.10).  
During ischemic period, a decrease in blood flow was observed with both methods. By release of 
arterial occlusion, an acute increase in blood flow due to hyperemic reaction and flow restoration 
occurred. Blood flow remained increased for some minutes and returned approximately to 
normal when resistance vessels regained their normal vascular tone (Figure 4-1). 
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Figure 4-1: Left forearm blood flow measurements by NIRS and SGP during three stages of 
experience. Dashed lines represent the mean ± standard error of the mean. 
 
Both methods showed an excellent reproducibility at baseline with ICC of 0.98 (95% CI: 0.96 – 
0.99; p < 0.0001) and 0.98 (95% CI: 0.95 – 0.99; p < 0.0001) for SGP and NIRS respectively.  
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Comparison of blood flow measurements during reactive hyperemia 
Blood flow measurements during reactive hyperemia with both methods showed an excellent 
linear relationship with a correlation coefficient of 0.91 (95%, p<0.0001) (Figure 4-2). 
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Figure 4-2: Linear regression between two modalities (SGP and NIRS). 
 
A Bland-Altman plot allowed a better comparison between the two methods.  As shown in 
Figure 4-3, NIRS tends to underestimate the high arterial inflows, at onset of reactive hyperemia 
stage. A linear regression between values of differences versus averages was performed. The 
slope was evaluated to be -0.1007 ± 0.02621 with a significant difference from zero. 
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Figure 4-3: Bland-Altman graph of flow measurements with linear regression. 
 
A two-way paired ANOVA test was performed to verify the effect of the two modalities on 
results during RH (Figure 4-4). Calculated F (0.33) is much smaller than critical threshold (2.44) 
indicating that there is no significant difference between flow measurement by the two 
modalities (p = 0.5723). 
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Figure 4-4: Blood flow measurements during RH by SGP and NIRS. Error bars represent 
standard error of the mean. 
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Comparison of blood flow measurements at baseline period and post-RH 
 
In order to determine whether blood flow reaches the baseline level at the end of the experiment, 
we compared blood flow measurements at baseline and post-RH phases. We performed a paired 
student’s t-test between repeated flow measurements at baseline and at the end of reactive 
hyperemia period (nine points). We observed a significant difference in flow measurements at 
post-RH stage compared to baseline for SGP (p=0.0003) and NIRS (p=0.0030) (Figure 4-5). 
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Figure 4-5: Comparison of flow measurements at baseline and post-RH period  
using paired student’s t-test. 
 
Blood flow measurement was performed on the right forearm by both the SGP and the NIRS 
methods to verify the probable influence of the left forearm reactive hyperemia. No significant 
variation in right forearm blood flow was observed during the three consecutive stages of the 
experiment.   
4.2 ηfactor and repeatability 
Measurements of ηfactor during three repeated experiments showed an excellent repeatability 
with ICC of 0.9313 (95%CI: 0.8368-0.9750). 
A one-way ANOVA test revealed that there is no significant difference among the mean 
measurements of the three repeated experiments (p=0.5779) (Figure 4-6).  
 49
0h 24h 27h
0
1
2
3
4
5
η f
ac
to
r
 
Figure 4-6: One-way ANOVA test showed that there is no significant difference among the three 
repeated groups of measurements. 
 
Repeated ηfactor were highly concordant with the correlation coefficients of 0.8763 (p<0.0001) 
and 0.8398 (p<0.0001) for repeated measurements at 24h and 3h respectively (Figure 4-7 and 4-
8). 
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Figure 4-7: Linear regression between repeated measurements at t=0 and t=24h. 
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Figure 4-8: Linear regression between repeated measurements at t=24h and t=27h. 
 
We calculated the time delay (in seconds) before the second detected peak (tpeak) occurs on the 
signal, based on the onset of the reactive hyperemia period. We obtained mean values of tpeak of: 
59.11 sec. (95%CI: 52.95-65.25), 57.65 sec. (95%CI: 52.66-65.65) and 52.65 sec. (95%CI: 
52.95-65.25) for experiments at t=0, t=24h and t=27h respectively. A one-way ANOVA test 
showed that there is no significant difference among the means of calculated tpeak at each 
experiment (p=0.4813) (Figure 4-9). 
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Figure 4-9: No significant difference was shown among the means tPeak at each experiment  
by one-way ANOVA test. 
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Chapter 5: Discussion 
5.1 Oxygenation monitor NIRO-200 
We showed that the measurement of the total hemoglobin variations during reactive hyperemia 
using an oxygenation monitor, Niro-200, is a good determinant of arterial inflow variations. We 
also performed flow measurements during reactive hyperemia by SGP and we presented data 
indicating that the NIRS technique yields values comparable to those obtained by SGP. Since the 
NIRS technique is currently used in clinic for cerebral and muscular tissue oxygenation 
monitoring, its application to other clinical tests such as reactive hyperemia and endothelial 
function might be of high interest. The Niro-200 tissular oximeter provides several parameters, 
which lead to measurements of blood volume variations during reactive hyperemia. We 
hypothesized that variations in total hemoglobin (oxygenated and deoxygenated) during 
consecutive venous occlusions are proportional to blood volume variations during these periods. 
The other advantage of Niro-200 compared to other clinical oxygenation monitor is the relatively 
high sampling rate (6 Hz), which is adequate for precisely calculating blood volume increase rate 
during venous occlusions (Figure 4-5). These characteristics, as well as its non-invasiveness may 
render this technology widespread in reactive hyperemia studies.    
5.2 Forearm blood flow 
In our study, we found a strong correlation between NIRS and SGP which is considered the gold 
standard. However, Bland-Altman plot showed that NIRS system tends to underestimate arterial 
inflow values at the onset of reactive hyperemia state while there is a sharp increase in blood 
flow (Figure 5-3). Many factors can explain lower flow values measured by NIRS. During the 
first two minutes of reactive hyperemia, we reduced venous occlusion times from 10 seconds to 
5 seconds. This selection allowed us to obtain more blood flow values during this 
physiologically important period of time. However, shorter venous occlusion times may reduce 
the accuracy of upslope calculation as it does not provide sufficient time for venous outflow. In 
addition, the adipose tissue causes the near infrared light to disperse which in turn may decrease 
the amplitude of the NIRS signal particularly in overweight patients. 
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Despite the complete arterial occlusion (systolic pressure + 50 mmHg) during the ischemia 
period, increases in total hemoglobin during venous occlusion were still observed, which caused 
the detection of a small blood flow during this period (Figure 4-1). This increase in the amount 
of total hemoglobin was found in other studies and was attributed to arterial blood pooling into 
the venous reservoir of the forearm muscle during the ischemic period  [33, 54].  
The calculation of the blood volume increment rate during repeated venous occlusions yielded 
forearm blood flow values. Repetitive inflation and deflation of the venous cuff was 
accompanied with slight movements of the forearms throughout the experience. These 
movements affect the SGP signal by sharp rises at the onset of cuff inflation, which appears on 
the recorded signal (Figure 5-1). In order to avoid blood flow overestimation, we excluded the 
first part of the SGP signal from the upslope calculation. However, the NIRSP signal remained 
unaffected by the aforementioned movement artifact (Figure 5-1).  
 
Figure 5-1: Blood volume variations during venous occlusions by SGP and NIRSP. 
 
Baseline arterial inflow measurements obtained with both methods were similar to those reported 
by other studies [25, 55]. However, arterial inflow values measured by both methods at the end 
of experiment are significantly smaller as compared to the baseline (NIRSP: 2.822 ± 0.30 
mL/100mL/min vs. 3.903 ± 0.30 mL/100mL/min). The equilibrium of vaso-active agents 
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produced by the endothelium is the main contributor to vascular tone regulation. The balance 
between vasodilator and vasoconstrictor agents is affected by reactive hyperemia, which seems 
to last for several hours [15]. We attributed the unsteadiness of the blood flow after reactive 
hyperemia to long-term changes in endothelial structure and morphology such as cell alignment 
along blood flow direction. The mentioned long-term changes in endothelial function and 
structure are due to an acute increase in the level of shear stress exerted on the endothelial cells 
which remains over a time period of more than 5 hours (Table 2-1) [15].    
The forearm blood flow measured by the NIRS was expressed in μmol/L/min. Concentration 
changes of hemoglobin is provided in μmol/L by the NIRS device. However, SGP is calibrated 
to provide blood flow variations in mL/100mL/min. The calculated blood flow variations by 
NIRS could be converted to mL/100mL/min by individual hemoglobin concentration. The 
conversion could be performed by considering individual Hb concentration, the molecular 
weight of Hb and the molar ratio between Hb and O2 (1:4). However, blood sampling is 
necessary to obtain individual Hb concentration. In order not to affect the non-invasive 
characteristic of our method, we converted blood flow units in μmol/L/min to mL/100mL/min 
using a universal calibration factor.  
5.3 Other studies 
A number of studies have been conducted on the assessment of endothelial function by the NIRS 
technique. But almost none of them had a similar methodology with which we could compare 
our results directly. 
De Blasi et al. measured forearm blood flow by NIRS at rest and during the hyperemic response 
induced by hand exercise [56]. They performed three repetitive venous occlusions, each lasting 
30 sec, during the reactive hyperemia to measure the blood volume changes. They presented the 
mean of the three measurements as the blood flow during reactive hyperemia. Nonetheless, they 
did not aim to obtain the blood flow variations over time. 
We obtained 9 and 27 measures of blood flow during baseline and reactive hyperemia 
respectively. They found higher blood flow values measured by SGP compared to NIRS which is 
in agreement with our results. They found an increase in total hemoglobin variation during the 
ischemic period which is also in agreement with our results. 
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Kragelj et al. studied post occlusive hyperemic response using NIRS through an ischemic 
condition [33]. They monitored variations in oxy- and deoxy-hemoglobin during ischemia and 
hyperemic response. They calculated the time after the release of the cuff until the initial values 
of HbO2 and the peak value in order to characterize endothelial function by variations in HbO2. 
They found a significant difference in measured parameters among the subjects in spite of the 
fact that they were selected among healthy subjects. On our side, we defined a factor on blood 
flow variations during reactive hyperemia to test the endothelial function and three repeated 
measurements show a very good repeatability for the defined factor.   
Edwards et al. described a methodology for blood flow measurement by NIRS [57]. The method 
is based on the Fick principle: flow could be quantified by relating the concentration of a tracer 
molecule in the vascular supply to the rate of tracer accumulation in the organ.  
They considered the increase in arterial HbO2 concentration as an intravascular tracer that is 
observable by NIRS. They applied a face mask to supply oxygen and nitrogen gases over the 
patient’s face and nose in order to control the inspired oxygen concentration. In their 
methodology, a series of measurements were averaged and the mean value was presented as 
blood flow. They compared the results to those obtained with the SGP method and they found a 
strong correlation. However, their study was not designed to examine the reactive hyperemic 
response through blood flow measurements. 
Some studies used methods other than post-ischemic reactive hyperemia, such as limb heating, to 
assess endothelial dependent vasodilatation. Local skin heating provides an increase in regional 
blood flow through a vasodilatation mechanism. However, the vasodilatory effect of heating is 
limited to the cutaneous layers and do not reach the muscular vascular bed [58]. On the other 
hand, it has been established that L-NMMA  has no effect on flow mediated dilatation after hand 
warming, indicating that vasodilatation caused by limb warming is endothelial independent [27].  
5.4 ηfactor and its clinical utility 
Few studies have been conducted to assess the contribution and quantification of NO to post-
ischemic reactive hyperemia in the human forearm. Meredith et al. studied forearm vasodilator 
responses in the absence and presence of NO synthesis inhibitor, L-NMMA, using the SGP 
method [59]. They defined the area under the flow-time curve at 1 and 5 min as hyperemic blood 
volumes. Their results indicated that in the presence of L-NMMA, the volume of blood at both 1 
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and 5 min reduced significantly. They demonstrated that NO contributes to post-ischemic 
vasodilatation. However, they did not characterize NO related and unrelated parts of the forearm 
blood flow during reactive hyperemia.  
We attributed the second blood flow peak during reactive hyperemia to NO dependent 
vasodilatation. This peak occurs, on average, 55.08 (95%CI: 52.07-59.89) seconds after the 
release of the arterial cuff (Figure 5-9). This time delay is in agreement with other studies 
findings of the maximal post-ischemic vasodilatation instant due to NO release, through direct 
measurement of arterial diameter by Doppler ultrasound during reactive hyperemia [26]. 
However, the release of NO has never been detected by blood flow variations during reactive 
hyperemia. 
We qualified the first peak as a sudden increase in blood flow due to the release of the arterial 
cuff, which was rapidly restricted by myogenic constriction. The first peak could represent the 
magnitude of the shear stress stimulus on the endothelial cells which trigger the release of NO. 
The amount of the released NO depends on the integrity of the endothelium as well as the 
magnitude of the stimulus [22]. Pyke et al. demonstrated that the shear rate stimulus varies 
between subjects while it remains constant within subjects [9]. Therefore, it is important to 
consider the amount of transferred stimulus to the endothelial cells, while interpreting the flow 
mediated vasodilatation response. We aimed to normalize the endothelium capacity in releasing 
relaxing factors according to the amount of shear stress by defining the ηfactor. A good level of 
repeatability was found within subjects for the calculated ηfactor (ICC=0.9313). We obtained 
mean ηfactor values of 1.065 (95%CI: 0.7009-1.430), 1.194 (95%CI: 0.6964-1.691) and 1.143 
(95%CI: 0.7105-1.576) for repeated measurements at t=0, t=24h and t=27h respectively. 
However, there is no such quantification in other studies to compare the results with. Perhaps the 
most interesting aspect of our findings is having defined a reproducible parameter within 
subjects, which could be useful in the quantification of the endothelium capacity in releasing NO 
compared to the amount of deposed shear stress to endothelial cells.  
As evaluation of endothelial function develops to become a practical mean in evaluation of 
patients at higher risk for cardiovascular events, it is important to question the clinical value of 
measuring the ηfactor. The ηfactor is a useful measure of NO dependent endothelial 
vasodilatation which may serve as an indication for cardiovascular risk factors. Atherosclerosis 
is present and clinically silent before the development of acute coronary events. At this point 
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cardiovascular disease risk factors are difficult to be screened because there is a time delay 
between the exposure to a risk factor and the cardiovascular disease manifestation. The ηfactor 
may be considered as a strong predictive tool in patients with mild or high level risk factors. This 
prediction is achieved through quantification of NO contribution to the hyperemic response. 
Identification of those patients experiencing a reduced endothelial function can then be followed 
by definition of a subgroup including patients who would benefit from aggressive medical or 
lifestyle treatment.  Treatment of risk factors in patients at high risk is associated with improved 
outcome. Furthermore, prevention of atherosclerosis at its early stage can have global health 
impact since it economizes several resources. There is currently no standard protocol for clinical 
application of the ηfactor; repeated measures of the factor is required to avoid environmental 
factor effects such as ingestion of fatty foods and smoking which may lead to a false positive 
prognostic.     
These potential utilities of the ηfactor measurement will obviously need further studies before it 
is applied in clinical practices. Some of these studies are detailed in Chapter 6.  
5.5 NIRS technique advantages and limitations 
A variety of non-invasive techniques have been developed to study reactive hyperemia. Strain 
gauge plethysmography has been employed as the gold standard. This method, however, does 
not provide regional information since it detects variations of an undetermined part of the limb 
volume and the axial resolution is so poor with this technique. On the other hand, SGP is too 
sensitive to movement artifact which may limit its applicability in a clinical setting. Ultrasound 
Doppler is a useful tool for blood flow measurement in relatively large blood vessels but the 
technique is not sensitive to blood flow in smaller vessels. MRI and PET techniques could serve 
for blood flow measurement with high temporal and spatial resolutions [43, 44]. However, their 
clinical uses in studies of reactive hyperemia are limited due to high cost and poor mobility.  
NIRS seems to be a promising alternative. It is not as sensitive to limb movement as SGP (Figure 
6-1). It can provide information on oxygenation levels in relatively deep muscle tissue. Unlike 
ultrasound Doppler, it is sensitive to small vessels such as arterioles and venules. Unlike MRI 
and PET, NIRS provides low spatial resolution but it provides relatively high temporal resolution 
while being inexpensive and mobile.  
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The NIRS monitors oxygenation levels in muscle tissue and resistive vessels such as arterioles, 
capillaries and venules. However, large vessels such as conductance vessels are out of scope for 
NIRS due to vessel wall thickness. 
Myoglobin has identical absorption spectra to hemoglobin and the two species are not separable 
by actual NIRS systems. However, in resting muscle with relatively low metabolism rate, 
myoglobin accounts for less than 10% of the total NIRS signal and its contribution to the signal 
remains constant [57]. In our study, we assumed that myoglobin saturation is constant during the 
experiment. 
The NIRS signal is a combination of three light absorbencies: hemoglobin in arterial space, 
hemoglobin in venous space and myoglobin in muscle. Therefore, the NIRS system is not able to 
distinguish arterial and venous flow. In our technique, however, we repeatedly cut the venous 
outflow to measure the arterial inflow specifically. 
One of the principle drawbacks of the NIRS method may be the qualitative nature of its 
measurements. The pathlength of NIR light in tissue is unknown for continuous light. Therefore, 
the light absorption level monitored by NIRS device does not provide absolute levels of oxy- and 
deoxy-hemoglobin concentration. The NIRS measurements are provided in variations compared 
with a zero point that is set at the beginning of each experiment.  
Skin and subcutaneous fat contribute a slight amount to oxygen saturation. Since adipose tissue 
thickness might be different between genders, additional care should be taken concerning this 
issue.  
This problem increases in patients with relatively thick fat layer and it would decrease the signal 
to noise ratio of the NIRS signal; this fact may limit the applicability of NIRS for overweight 
patients. Standardization of the NIRS setup in blood flow measurement is an important issue 
since the displacement of the NIRS probes has a remarkable effect on the amplitude of the 
signal.  
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Chapter 6: Conclusion  
We assessed the efficiency of using NIRS to evaluate changes in vascular tone during reactive 
hyperemia. To characterize blood flow variations during this period through endothelial 
dependent and independent responses, two experiments were designed. The results of the first 
experiment showed a strong correlation between measurement of the blood flow by NIRS and 
SGP. This study indicated that measurement of forearm arterial inflow is possible in a precise 
and totally non-invasive way through NIRS. The results could be used to obtain valuable new 
information about the integrity of peripheral vascular endothelium in releasing vasodilator 
agents. Therefore, in the second experiment, we presented a repeatable factor which was mainly 
defined to reveal endothelium capacity in releasing of vasodilator agents. The proposed factor 
could be served as determinant of NO contribution to hyperemic response. This new factor might 
be useful in better understanding the endothelial function in patients with atherosclerotic risk 
factors. This was the first series of studies to investigate the possibility of endothelial function 
quantification through measurements of forearm blood flow.  
Future research to validate the capacity of ηfactor in endothelial function quantification is 
proposed as:  
1) Assessment of the ηfactor obtained through NIRS with other non-invasive techniques of blood 
flow measurement such as Ultrasound Doppler; this study could lead to the examination of the 
reproducibility of ηfactor by other established techniques of blood flow measurements.  
2) Evaluation of the ηfactor obtained in presence and absence of NO synthesis inhibitors; this 
study could lead to quantify the contribution of endothelium-derived NO to post-ischemic 
reactive hyperemia response.  
3) Comparison of the ηfactor obtained in a group of patient with atherosclerotic diseases with 
ones obtained in a group of control; this study investigates the ability of the ηfactor in 
differentiating the group of patients from the control group. Significant results would lead to 
determine a threshold for impaired reactive hyperemic responses. 
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